Ontology highlight
ABSTRACT:
SUBMITTER: Pourzia AL
PROVIDER: S-EPMC10101951 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
Pourzia Alexandra L AL Olson Michael L ML Bailey Stefanie R SR Boroughs Angela C AC Aryal Aditi A Ryan Jeremy J Maus Marcela V MV Letai Anthony A
Cell death & disease 20230413 4
Chimeric antigen receptor (CAR) T cell therapy is an FDA-approved treatment for several hematologic malignancies, yet not all patients respond to this treatment. While some resistance mechanisms have been identified, cell death pathways in target cancer cells remain underexplored. Impairing mitochondrial apoptosis via knockout of Bak and Bax, forced Bcl-2 and Bcl-XL expression, or caspase inhibition protected several tumor models from CAR T killing. However, impairing mitochondrial apoptosis in ...[more]